Trademark: 88662693
Status Date
Tuesday, June 21, 2022
Filing Date
Monday, October 21, 2019
Published for Opposition
Tuesday, August 18, 2020
Abandoned Date
Tuesday, June 7, 2022
35 business consulting and management in the fields of medical research, pharmaceutical development and clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of pharmaceutical development, namely, management and compilation of computerized databases in the field of pharmaceutical development for business purposes; business consulting and management in the field of pharmaceutical development, namely, management and compilation of computerized databases in the field of medical research for business purposes; all of the foregoing excluding the field of digenesis
42 providing medical and scientific research information in the fields of medical research, pharmaceutical development and clinical trials; consulting services for others in the field of design and planning of clinical trials; consulting services for others in the fields of medical research and pharmaceutical development; consulting services for others in the fields of medical research and pharmaceutical development, namely, providing digital models of patients for use as simulated control subjects; consulting services for others in the field of design and planning of clinical trials, namely, providing digital models of patients for use as simulated control subjects for clinical trials; providing data analytics and artificial intelligence in the nature of non-downloadable software, for use in the design and planning of clinical trials; providing data analytics and artificial intelligence in the nature of non-downloadable software, for use in medical research and pharmaceutical development; providing data analytics and artificial intelligence in the nature of non-downloadable software, for use in the life sciences field for the purpose of research, development, and commercialization; providing a website featuring educational information in the fields of medical research, pharmaceutical development, clinical trials and artificial intelligence; all of the foregoing excluding the field of digenesis
Jun 21, 2022
Abandonment Notice E-Mailed - Failure To Respond
Jun 21, 2022
Abandonment - Failure To Respond Or Late Response
Dec 6, 2021
Notification Of Non-Final Action E-Mailed
Dec 6, 2021
Non-Final Action E-Mailed
Dec 6, 2021
Su - Non-Final Action - Written
Nov 9, 2021
Statement Of Use Processing Complete
Oct 20, 2021
Use Amendment Filed
Nov 5, 2021
Case Assigned To Intent To Use Paralegal
Oct 20, 2021
Teas Statement Of Use Received
Oct 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 8, 2021
Sou Extension 2 Granted
Oct 8, 2021
Sou Extension 2 Filed
Oct 8, 2021
Teas Extension Received
Apr 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2021
Sou Extension 1 Granted
Apr 12, 2021
Sou Extension 1 Filed
Apr 12, 2021
Teas Extension Received
Oct 13, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 18, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2020
Published For Opposition
Jul 29, 2020
Notification Of Notice Of Publication E-Mailed
Jul 13, 2020
Approved For Pub - Principal Register
May 28, 2020
Teas/Email Correspondence Entered
May 27, 2020
Correspondence Received In Law Office
May 27, 2020
Teas Response To Office Action Received
Apr 16, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 16, 2020
Teas Change Of Correspondence Received
Apr 16, 2020
Teas Change Of Owner Address Received
Feb 3, 2020
Notification Of Non-Final Action E-Mailed
Feb 3, 2020
Non-Final Action E-Mailed
Feb 3, 2020
Non-Final Action Written
Jan 27, 2020
Assigned To Examiner
Oct 25, 2019
New Application Office Supplied Data Entered In Tram
Oct 24, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
